1) John E Bennett, Raphael Dolin, Martin J Blaser: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 9th ed, Elsevier, Philadelphia, 2020;2669
2) WHO publishes list of bacteria for which new antibiotics are urgently needed. https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed
3) Bialek-Davenet S, Mayer N, Vergalli J, et al: In-vivo loss of carbapenem resistance by extensively drug-resistant Klebsiella pneumoniae during treatment via porin expression modification. Sci Rep 2017;7(1):6722
4) Ho PL, Cheung YY, Wang Y, et al. Characterization of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae from a healthcare region in Hong Kong. Eur J Clin Microbiol Infect Dis 2016;35(3):379-85
5) Diene SM, Rolain JM. Carbapenemase genes and genetic platforms in Gram- negative bacilli: Enterobacteriaceae, Pseudomonas and Acinetobacter species. Clin Microbiol Infect 2014;20(9):831-8
6) Cornaglia G, Giamarellou H, Rossolini GM. Metallo-beta-lactamases: a last frontier for beta-lactams? Lancet Infect Dis 2011;11(5):381-93
7) Logan LK, Weinstein RA. The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace. J Infect Dis 2017;215(suppl_1):S28-36
8) Nordmann P, Naas T, Poirel L. Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2011;17(10):1791-8.
9) Daikos GL, Tsaousi S, Tzouvelekis LS, et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob Agents Chemother 2014;58(4):2322-8
10) Candevir Ulu A, Guven Gokmen T, Kibar F, et al. Molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae at a Turkish centre: Is the increase of resistance a threat for Europe? Journal of global antimicrobial resistance 2017;11:10-6.
11) Osano E, Arakawa Y, Wacharotayankun R, et al. Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob Agents Chemother 1994;38(1):71-8.
12) Takahashi A, Yomoda S, Kobayashi I, et al. Detection of carbapenemase-producing Acinetobacter baumannii in a hospital. J Clin Microbiol 2000;38(2):526-9.
13) Wang JT, Wu UI, Lauderdale TL, et al. Carbapenem-nonsusceptible Enterobacteriaceae in Taiwan. PLoS One 2015;10(3):e0121668.
14) Lai K, Ma Y, Guo L, et al. Molecular characterization of clinical IMP-producing Klebsiella pneumoniae isolates from a Chinese Tertiary Hospital. Ann Clin Microbiol Antimicrob 2017;16(1):42.
15) Yano H, Kuga A, Okamoto R, et al. Plasmid-encoded metallo-beta-lactamase (IMP- 6) conferring resistance to carbapenems, especially meropenem. Antimicrob Agents Chemother 2001;45(5):1343-8.
16) Shigemoto N, Kayama S, Kuwahara R, et al. A novel metallo-β-lactamase, IMP-34, in Klebsiella isolates with decreased resistance to imipenem. Diagn Microbiol Infect Dis 2013;76(1):119-21.
17) 国立感染症研究所薬剤耐性研究センター，国立感染症研究 所感染症疫学センター，全国地方衛生研究所．カルバペネム耐性腸内細菌科細菌（carbapenem-resistant Enterobacteriaceae: CRE）病原体サーベイランス, 2017 年. IASR 2018;39:162-163
18) 安部朋子, 永田由美, 松井真理, 他. プラスミド水平伝達を介し多菌種へ耐性伝播した IMP-1 メタロ-β-ラクタマーゼ産生腸内細菌科細菌による院内感染事例.日本臨床微生物学雑誌 2017;27(3):158-67
19) Hayakawa K, Nakano R, Hase R, et al. Comparison between IMP carbapenemase- producing Enterobacteriaceae and non-carbapenemase-producing Enterobacteriaceae: a multicentre prospective study of the clinical and molecular epidemiology of carbapenem-resistant Enterobacteriaceae. J Antimicrob Chemother 2020;75(3):697-708
20) Tzouvelekis LS, Markogiannakis A, Psichogiou M, et al. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev 2012;25(4):682-707
21) Kaye KS, Harris AD, Samore M, et al. The case-case-control study design: addressing the limitations of risk factor studies for antimicrobial resistance. Infect Control Hosp Epidemiol 2005;26(4):346-51
22) Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40(5):373-83
23) Ben-David D, Kordevani R, Keller N, et al. Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect 2012;18(1):54-60
24) Centers for Disease Control and Prevention. Types of Healthcare-associated Infections. https://www.cdc.gov/hai/infectiontypes.html
25) Clinical & Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. 22nd informational supplement. M100–S22. Wayne, 2012; 45-9
26) Livermore DM, Warner M, Mushtaq S. Evaluation of the chromogenic Cica-beta- Test for detecting extended-spectrum, AmpC and metallo-beta-lactamases. J Antimicrob Chemother 2007;60(6):1375-9
27) Kitao T, Miyoshi-Akiyama T, Tanaka M, et al. Development of an immunochromatographic assay for diagnosing the production of IMP-type metallo- beta-lactamases that mediate carbapenem resistance in Pseudomonas. J Microbiol Methods 2011;87(3):330-7
28) Shibata N, Doi Y, Yamane K, et al. PCR Typing of Genetic Determinants for Metallo-β-Lactamases and Integrases Carried by Gram-Negative Bacteria Isolated in Japan, with Focus on the Class 3 Integron. J Clin Microbiol 2003;41(12):5407- 13
29) Ramos-Castaneda JA, Ruano-Ravina A, Barbosa-Lorenzo R, et al. Mortality due to KPC carbapenemase-producing Klebsiella pneumoniae infections: Systematic review and meta-analysis: Mortality due to KPC Klebsiella pneumoniae infections. J Infect 2018;76(5):438-48
30) 鈴木里和, 松井真理, 鈴木仁人, 他. 腸内細菌科カルバペネマーゼ産生菌の検出に適したスクリーニング薬剤の検討. IASR 2014;35:156-7
31) Livermore DM, Warner M, Mushtaq S. Evaluation of the chromogenic Cica-β-Test for detecting extended-spectrum, AmpC and metallo-β-lactamases. J Antimicrob Chemother 2007;60(6):1375-9
32) Lavigne JP, Pfeiffer C, Vidal L, et al. Rapid detection of multidrug resistant Gram-negative bacilli by Cica-Beta-Test strips. Pathol Biol (Paris) 2011;59(1):e7-11
33) 重高 正行, 村谷 哲郎, 小林 とも子, 他. Metallo-β-lactamase 産生株検出における市販の確認セットの比較. 感染症学雑誌 2006;80(4):391-8
34) Kitao T, Miyoshi-Akiyama T, Tanaka M, et al. Development of an immunochromatographic assay for diagnosing the production of IMP-type metallo-β-lactamases that mediate carbapenem resistance in Pseudomonas. J Microbiol Methods 2011;87(3):330-7.
35) Notake S, Matsuda M, Tamai K, et al. Detection of IMP metallo-β-lactamase in carbapenem-nonsusceptible Enterobacteriaceae and non-glucose-fermenting Gram-negative rods by immunochromatography assay. J Clin Microbiol 2013;51(6):1762-8.
36) Hayakawa K, Miyoshi-Akiyama T, Kirikae T, et al. Molecular and epidemiological characterization of IMP-type metallo-beta-lactamase-producing Enterobacter cloacae in a Large tertiary care hospital in Japan. Antimicrob Agents Chemother 2014;58(6):3441-50
37) Pang F, Jia XQ, Zhao QG, et al. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals. Ann Clin Microbiol Antimicrob 2018;17(1):13
38) Yan JJ, Lee NY, Chen HM, et al. Bloodstream infections caused by IMP-8- producing Enterobacteriaceae isolates: the need for clinical laboratory detection of metallo-beta-lactamases? European journal of clinical microbiology & infectious diseases : official publication of the Eur J Clin Microbiol Infect Dis 2013;32(3):345-52
39) Tamma PD, Goodman KE, Harris AD, et al. Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia. Clin Infect Dis 2017;64(3):257-64
40) Yamamoto N, Asada R, Kawahara R, et al. Prevalence of, and risk factors for, carriage of carbapenem-resistant Enterobacteriaceae among hospitalized patients in Japan. J Hosp Infect 2017;97(3):212-7
41) Limbago BM, Rasheed JK, Anderson KF et al. IMP-producing carbapenem- resistant Klebsiella pneumoniae in the United States. J Clin Microbiol 2011;49(12):4239-45
42) 荒川宜親. 腸内細菌科菌種におけるカルバペネム耐性メカニズムとその特長および動向. IASR 2014;35:283-4
43) Voulgari E, Zarkotou O, Ranellou K, et al. Outbreak of OXA-48 carbapenemase- producing Klebsiella pneumoniae in Greece involving an ST11 clone. J Antimicrob Chemother 2013;68(1):84-8
44) Ramos-Castañeda JA, Ruano-Ravina A, Barbosa-Lorenzo R, et al. Mortality due to KPC carbapenemase-producing Klebsiella pneumoniae infections: Systematic review and meta-analysis: Mortality due to KPC Klebsiella pneumoniae infections. J Infect 2018;76(5):438-48
45) Xu L, Sun X, Ma X. Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob 2017;16(1):18
46) Rahman M, Shukla SK, Prasad KN, et al. Prevalence and molecular characterisation of New Delhi metallo-β-lactamases NDM-1, NDM-5, NDM-6 and NDM-7 in multidrug-resistant Enterobacteriaceae from India. Int J Antimicrob Agents 2014;44(1):30-7
47) Falcone M, Tiseo G, Antonelli A, et al. Clinical Features and Outcomes of Bloodstream Infections Caused by New Delhi Metallo-β-Lactamase-Producing Enterobacterales During a Regional Outbreak. Open Forum Infect Dis 2020;7(2):ofaa011
48) Stewart A, Harris P, Henderson A, et al. Treatment of Infections by OXA-48- Producing Enterobacteriaceae. Antimicrobial agents and chemotherapy 2018;62(11):e01195-18
49) Rodríguez OL, Sousa A, Pérez-Rodríguez MT, et al. Mortality-related factors in patients with OXA-48 carbapenemase-producing Klebsiella pneumoniae bacteremia. Medicine 2021;100(14) :e24880
50) Yamakawa H, Kosai K, Akamatsu N, et al. Molecular and epidemiological analysis of IMP-1 metallo-beta-lactamase-producing Klebsiella pneumoniae in a tertiary care hospital in Japan. J Infect Chemother 2019;25(4):240-246
51) Freire MP, de Oliveira Garcia D, Cury AP, et al. Outbreak of IMP-producing carbapenem-resistant Enterobacter gergoviae among kidney transplant recipients. J Antimicrob Chemother 2016;71(9):2577-85
52) Hagiya H, Yamamoto N, Kawahara R, et al. Risk factors for fecal carriage of IMP- 6-producing Enterobacteriaceae at a long-term care hospital in Japan: A follow-up report from the northern Osaka multicentre study group. J Infect Chemother 2018;24(9):769-772
53) Leung GH, Gray TJ, Cheong EY, et al. Persistence of related bla-IMP-4 metallo- beta-lactamase producing Enterobacteriaceae from clinical and environmental specimens within a burns unit in Australia - a six-year retrospective study. Antimicrob Resist Infect Control 2013;2(1):35
54) Cronin KM, Poy Lorenzo YS, Olenski ME, et al. Risk factors for KPC-producing Enterobacteriaceae acquisition and infection in a healthcare setting with possible local transmission: a case-control study. J Hosp Infect 2017;96(2):111-5.
55) Gasink LB, Edelstein PH, Lautenbach E, et al. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Infect Control Hosp Epidemiol 2009;30(12):1180-5
論文の公開元へ
